Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell, Cutaneous × Vorinostat × Clear all

NCT03713320 2022-04-08

SOLAR

Phase 2 Terminated

37 enrolled 23 charts

DermatologicLymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Mycosis Fungoides, Neoplasms, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

NCT00958074 2018-10-18

Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma

Phase 2 Terminated

11 enrolled 11 charts

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT00091559 2017-04-05

Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)

Phase 2 Completed

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT02943642 2016-10-25

Resimmune®

Phase 2 Unknown

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous